All In MedTech

Device Trial Radar · NCT06062329

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism

Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

110

Actual

Start

Dec 13, 2023

Primary completion

May 4, 2025

Study completion May 29, 2025

Sponsor

Lead sponsor
Imperative Care, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 2, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism

Conditions

  • Acute Pulmonary Embolism
  • Thromboembolism
  • Emboli, Pulmonary
  • Thrombosis
  • Thrombus; Embolism
  • Embolism
  • Cardiovascular Diseases
  • Vascular Diseases

Interventions

  • Symphony Thrombectomy SystemDevice

    The Symphony Thrombectomy System will be used to restore blood flow to the pulmonary arteries by removing thrombus/embolus/clot using aspiration and mechanical clot engagement.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Major Adverse EventsTime frame: 48 hours
  2. Mean Reduction of RV/LV RatioTime frame: Baseline to 48 hours

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • Huntsville Hospital

    Huntsville, Alabama

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • First Coast Cardiovascular Institute

    Jacksonville, Florida

16 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.